Alzheimer’s Therapeutics Market Size to Grow from $3.94 Billion in 2024 to $7.96 Billion by 2033 at 9.3% CAGR – Strategic Revenue Insights (SRI)
Publish Date: 2026-02-13 03:39:00
Source Domain: industrytoday.co.uk
- The Alzheimer’s Therapeutics market was valued at $3.94 billion in 2024 and is projected to reach $7.96 billion by 2033, growing at a CAGR of 9.3%.
- The market is experiencing transformative growth, driven by advancements in science and increased investments in neurodegenerative care.
- The Alzheimer’s Therapeutics sector is shifting towards disease-modifying therapies targeting amyloid beta plaques and tau protein pathologies fueled by regulatory approvals of monoclonal antibodies.
- Personalized medicine and advanced diagnostic technologies like biomarker testing and neuroimaging diagnostics are contributing to better early diagnosis and treatment.
- The market’s expansion is supported by collaborations, both public-private partnerships and academic collaborations to boost research and innovation in therapies.
